Repligen (RGEN) Cash & Current Investments (2010 - 2026)
Repligen's (RGEN) quarterly Cash & Current Investments came in at $1.0 billion in Q2 2026, up 43.06% year-over-year from $708.9 million in Q2 2025, and up 2.81% quarter-over-quarter from $986.4 million in Q1 2026.
Analysis
Repligen (RGEN) Cash & Current Investments (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Cash & Current Investments for 17 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Current Investments rose 43.06% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 43.06% increase from a year earlier, with the FY2025 full-year figure at $969.2 million, up 27.93% from the prior year.
- Cash & Current Investments was $1.0 billion for Q2 2026 at Repligen, up from $986.4 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $1.0 billion in Q2 2026 and troughed at $573.4 million in Q3 2022.
- A 5-year average of $735.4 million and a median of $728.8 million in 2025 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments slipped 18.77% in 2022 and surged 43.06% in 2026, its largest moves.
- Over 5 years, Cash & Current Investments stood at $623.8 million in 2022, then rose by 20.45% to $751.3 million in 2023, then rose by 0.84% to $757.6 million in 2024, then gained by 27.93% to $969.2 million in 2025, then climbed by 4.63% to $1.0 billion in 2026.
- The last three Cash & Current Investments figures came in at $1.0 billion (Q2 2026), $986.4 million (Q1 2026), and $969.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 4.06 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 4.35 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 1.76 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 1.17 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 1.02 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 264.71 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 1.62 Bn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 1.01 Bn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 552.03 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 217.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Bn |
| Mar 31, 2026 | 986.41 Mn |
| Dec 31, 2025 | 969.24 Mn |
| Sep 30, 2025 | 748.75 Mn |
| Jun 30, 2025 | 708.86 Mn |
| Mar 31, 2025 | 697.23 Mn |
| Dec 31, 2024 | 757.64 Mn |
| Sep 30, 2024 | 783.96 Mn |
| Jun 30, 2024 | 809.15 Mn |
| Mar 31, 2024 | 780.62 Mn |
| Dec 31, 2023 | 751.32 Mn |
| Sep 30, 2023 | 630.78 Mn |
| Jun 30, 2023 | 603.66 Mn |
| Mar 31, 2023 | 618.02 Mn |
| Dec 31, 2022 | 623.76 Mn |
| Sep 30, 2022 | 573.36 Mn |
| Jun 30, 2022 | 596.51 Mn |
| Mar 31, 2022 | 584.64 Mn |
| Dec 31, 2021 | 603.81 Mn |
| Sep 30, 2021 | 621.10 Mn |